Stay updated with breaking news from Charitable Trust Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pulsed field ablation lowered the odds of high residual atrial arrhythmia burden compared with thermal ablation for patients with atrial fibrillation at 1 year, according to a subanalysis of the ADVENT trial presented at Heart Rhythm 2024. As Healio previously reported, in the main results of ADVENT, pulsed field ablation (Farapulse, Boston Scientific) was noninferior to thermal ablation
FOR IMMEDIATE RELEASE Contact: Ilana Nikravesh
Women with atrial fibrillation (AF) undergoing a procedure called pulsed field ablation (PFA) have just as good outcomes as men with AF undergoing the same procedure, according to a large-scale international study led by the Icahn School of Medicine at Mount Sinai.
In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show. Pulsed field ablation (PFA) is a novel AF ablation modality that has demonstrated preferential tissue ablation with no esophageal damage in early clinical trials, Vivek Y. Reddy, MD, director of
Late breaking analysis of one-year outcomes from the inspIRE clinical study demonstrated early success at the prespecified interim analysis